Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
Eledon Pharmaceuticals, Inc.(NasdaqCM:ELDN) added to Russell 3000 Growth Index